News ReleasesRSS
- Apr 26, 2024 Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
- Apr 24, 2024 Chugai Announces 2024 1st Quarter Results
- Apr 24, 2024 F. Hoffmann-La Roche Announces First Quarter Sales 2024
- Apr 19, 2024 Alecensa Approved by FDA as the First Adjuvant Treatment for People with ALK-Positive Early-Stage Non-Small Cell Lung Cancer
- Apr 19, 2024 Chugai In-Licenses RNAi Therapeutic Zilebesiran for Hypertension with High Cardiovascular Risk
What's NewRSS
- Apr 24, 2024 Temporary Audio Streaming of Conference on FY 2024.12 Q1 Financial Results
- Apr 24, 2024 Conference on FY 2024.12 Q1 Financial Results
- Apr 24, 2024 Financial Results for First Quarter of Fiscal Year 2024 (Jan-Mar 2024)
- Mar 28, 2024 Notice of Resolutions of the 113th Annual General Meeting
- Mar 28, 2024 Notice Regarding Year-End Dividend for the Fiscal Year ending December, 2023